Literature DB >> 32076474

Predictive role of interleukin-6 and CAT score in mechanical ventilation in patients with chronic obstructive pulmonary disease at the acute exacerbation stage in the emergency department.

Wei Bi1,2, Yan Sun3, Lin-Qin Ma1,2, Cai-Jun Wu1,2.   

Abstract

BACKGROUND: The study aimed to evaluate the predictive role of interleukin-6 (IL-6) and chronic obstructive pulmonary disease (COPD) assessment test (CAT) score in mechanical ventilation (MV) in COPD patients at the acute exacerbation stage in the emergency department (ED).
METHODS: For a one-year period, among adult patients in the ED who met the criteria of acute exacerbation of COPD, 158 who received MV within 48 hours after admission were compared to 294 who didn't require MV within the same period after admission. IL-6 level and CAT score were compared between the two groups. The predicted value of IL-6 and CAT score was assessed by logistic regression analysis and a receiver operating characteristic (ROC) curve.
RESULTS: The IL-6 and CAT scores in the 158 MV patients were much higher than those without. IL-6 and CAT scores were independent predictors of MV within 48 hours using logistic regression analysis (IL-6: odds ratio [OR] 1.053, 95% confidence interval [CI] 1.039-1.067, P<0.001; CAT score: OR 1.122, 95% CI 1.086-1.159, P<0.001). The combination of IL-6 and CAT scores (area under ROC curve [AUC] 0.826, 95% CI 0.786-0.866, P<0.001) improved the accuracy of predicting MV within 48 hours when compared with IL-6 (AUC 0.752, 95% CI 0.703-0.800, P<0.001) and CAT scores alone (AUC 0.739, 95% CI 0.692-0.786, P<0.001). The sensitivity and specificity were 69.6%, 74.1%, 75.32% and 63.6%, respectively.
CONCLUSION: The combined of IL-6 and CAT scores is useful for evaluating the risk of COPD patients at acute exacerbation in ED, and can provide a predictive value for MV or not within 48 hours. Copyright: © World Journal of Emergency Medicine.

Entities:  

Keywords:  COPD assessment test; Chronic obstructive pulmonary disease (COPD); Interleukin-6; Receive operating characteristic curve; Risk stratification

Year:  2020        PMID: 32076474      PMCID: PMC7010523          DOI: 10.5847/wjem.j.1920-8642.2020.02.005

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  2 in total

1.  Effects of Maxingloushi decoction on immune inflammation and programmed death markers in mice with chronic obstructive pulmonary disease.

Authors:  Li Li; Jun Yan; Lin-Qin Ma; Wei Bi; Cai-Jun Wu
Journal:  World J Emerg Med       Date:  2022

Review 2.  COVID-19: In the Eye of the Cytokine Storm.

Authors:  Roberto de la Rica; Marcio Borges; Marta Gonzalez-Freire
Journal:  Front Immunol       Date:  2020-09-24       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.